SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 413 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $14,358,000 | +0.9% | 192,650 | +130.9% | 0.07% | -13.6% |
| Q4 2020 | $14,223,000 | +86.4% | 83,424 | +47.6% | 0.08% | +19.1% |
| Q3 2020 | $7,630,000 | -20.7% | 56,538 | -8.8% | 0.07% | -46.0% |
| Q2 2020 | $9,626,000 | -55.0% | 62,001 | -71.6% | 0.13% | -37.3% |
| Q1 2020 | $21,390,000 | +36.0% | 218,670 | +79.5% | 0.20% | -19.0% |
| Q4 2019 | $15,724,000 | +67.5% | 121,855 | -2.2% | 0.25% | +48.5% |
| Q3 2019 | $9,387,000 | -29.4% | 124,623 | +42.4% | 0.17% | -36.0% |
| Q2 2019 | $13,294,000 | +156.8% | 87,492 | +101.5% | 0.26% | +90.5% |
| Q1 2019 | $5,177,000 | – | 43,431 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |